FDA says Emmons Livestock sold a cow with drug residues above limits and kept medicated cattle unsafely.
What happened
FDA inspected Emmons Livestock's cattle dealing operation in Maysville, Kentucky, on August 17, September 7, and September 16, 2022. USDA testing of liver tissue from a cow the firm sold for slaughter found florfenicol at 6.70 parts per million (ppm) and tilmicosin at 1.52 ppm, above FDA tolerances of 3.7 ppm and 1.2 ppm. FDA also found unclean medicated-water containers, incomplete treatment records, no separation of treated cattle, expired drugs on site, and extra-label use of Increxxa by other people on animals the firm did not own.
What FDA found
The firm sold a cow for slaughter whose liver had florfenicol at 6.70 ppm and tilmicosin at 1.52 ppm, above allowed limits.
21 U.S.C. § 342(a)(2)(C)(ii); 21 CFR 556.283(b)(1)(i); 21 CFR 556.735(b)(1)(i)The firm did not ask about the medication status of cattle it transported, purchased, and delivered for sale at an auction barn.
21 U.S.C. § 331(a)The firm held animals under insanitary conditions; it did not clean water containers, and medicated water remained where healthy animals could reach it.
21 U.S.C. § 342(a)(4)Treatment records were incomplete, and treated cattle were not identified or segregated from other cattle, with no hospital pen for sick or medicated animals.
The firm lacked an adequate system to account for drugs, and expired drugs were observed on site.
The firm let other people, including employees, use Increxxa (tulathromycin) on animals it did not own without a valid veterinarian-client-patient relationship, which FDA says makes the drug adulterated (unsafe).
21 CFR 530.11(a); 21 U.S.C. § 351(a)(5); 21 U.S.C. § 331(b)
What FDA wants
FDA asks the firm to write to the agency within 15 working days with the specific steps it has taken to correct the violations and prevent recurrence, with supporting documents. If corrections will take longer, the firm must give the reason and a completion date.
Who should pay attention
- cattle auction barns and livestock dealers
- cattle producers who use medicated water or drugs
- slaughterhouses and meat processors that receive cattle
This is a summary. Read the original letter on fda.gov.